| Title |
Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and “New Old Friends”
|
|---|---|
| Published in |
Frontiers in immunology, September 2020
|
| DOI | 10.3389/fimmu.2020.02059 |
| Pubmed ID | |
| Authors |
Thomas-Oliver Kleen, Alicia A. Galdon, Andrew S. MacDonald, Angus G. Dalgleish |
X Demographics
The data shown below were collected from the profiles of 108 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 23 | 21% |
| United Kingdom | 7 | 6% |
| Spain | 3 | 3% |
| United States | 2 | 2% |
| Austria | 1 | <1% |
| Netherlands | 1 | <1% |
| Croatia | 1 | <1% |
| Canada | 1 | <1% |
| Switzerland | 1 | <1% |
| Other | 1 | <1% |
| Unknown | 67 | 62% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 93 | 86% |
| Scientists | 12 | 11% |
| Practitioners (doctors, other healthcare professionals) | 2 | 2% |
| Science communicators (journalists, bloggers, editors) | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 135 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 135 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 20 | 15% |
| Researcher | 18 | 13% |
| Student > Bachelor | 15 | 11% |
| Student > Ph. D. Student | 13 | 10% |
| Other | 10 | 7% |
| Other | 21 | 16% |
| Unknown | 38 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 38 | 28% |
| Biochemistry, Genetics and Molecular Biology | 12 | 9% |
| Immunology and Microbiology | 9 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 6% |
| Nursing and Health Professions | 6 | 4% |
| Other | 21 | 16% |
| Unknown | 41 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 69. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2024.
All research outputs
#631,855
of 25,800,372 outputs
Outputs from Frontiers in immunology
#568
of 32,412 outputs
Outputs of similar age
#18,322
of 426,770 outputs
Outputs of similar age from Frontiers in immunology
#32
of 898 outputs
Altmetric has tracked 25,800,372 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,412 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,770 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 898 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.